Garlic

What the evidence actually shows

Garlic is one of the better-studied supplements for cardiovascular health, with a research base going back several decades. The strongest current evidence supports modest reductions in LDL cholesterol and total cholesterol, lower blood pressure (particularly in people with mild hypertension), reduced arterial stiffness, improved HDL cholesterol, lower platelet aggregation, and reductions in common cold frequency and duration with regular intake.

The evidence is good for modest improvements in fasting blood glucose and HbA1c, reductions in C-reactive protein, and lower risk of upper respiratory infections in older adults — effects that mostly emerge with 8–12 weeks of consistent use rather than acutely.

What garlic does poorly is dramatically transform any single cardiovascular metric. The blood pressure effect averages around 5–8 mmHg systolic in hypertensive adults, the LDL effect around 5–10%. These are real but modest changes — meaningful as part of a broader cardiovascular strategy, not as a replacement for medication where it's clinically needed.

The form matters substantially. Fresh raw garlic, aged garlic extract (AGE), and standardised garlic powder all show benefit in trials. Cooked garlic loses most of its allicin (the precursor to the active compounds) and shows reduced clinical effect. Most modern research uses aged garlic extract, which preserves activity and is gentler on the stomach.

How it works

Garlic contains a sulphur compound called alliin that converts to allicin when the clove is crushed or chewed — and from allicin to a family of further sulphur compounds (ajoene, vinyldithiins, sulfides) that produce most of garlic's biological effects.

These compounds work through several mechanisms: inhibition of cholesterol synthesis in the liver (acting on a similar pathway to statins, though much more weakly), modest vasodilation through nitric oxide pathways, inhibition of platelet aggregation (a mild blood-thinning effect), and antimicrobial activity against several pathogens involved in respiratory and gastrointestinal infections.

The breadth of mechanism explains why garlic shows benefit across several cardiovascular and immune outcomes simultaneously. It also explains the consistent finding that effects emerge gradually with sustained use rather than acutely.

Who benefits most — and who should be cautious

The clearest beneficiaries are people with mild-to-moderate hypertension (resting blood pressure in the 130–160 systolic range), elevated LDL cholesterol not yet requiring statin therapy, frequent upper respiratory infections in winter, and older adults for general cardiovascular and immune support.

It is less reliably useful for people with severe hypertension (where pharmaceutical treatment is the priority) or for those without identifiable cardiovascular risk factors.

The main cautions are bleeding risk and interactions. Garlic has a mild antiplatelet effect, which can compound the effect of anticoagulants (warfarin, clopidogrel) or NSAIDs. Discontinue garlic supplements 7–10 days before scheduled surgery. People taking HIV protease inhibitors should avoid high-dose garlic, which can reduce drug levels meaningfully.

Gastrointestinal side effects — heartburn, reflux, body odour — are common with raw garlic and minimal with aged garlic extract.

How to take it

Form. Aged garlic extract (AGE) is the most studied and best-tolerated supplement form. Standardised garlic powder tablets (delivering 1.3% allicin or equivalent) also work but cause more gastrointestinal symptoms. Raw garlic in food is biologically active but inconsistent in dose.

Dose.

• Aged garlic extract: 600–1,200 mg/day, divided
• Standardised garlic powder: 600–900 mg/day, providing roughly 5,000–6,000 micrograms of allicin potential
• Culinary: 1–2 cloves daily (raw or lightly cooked) provides a modest dose

Timing. With food to reduce gastrointestinal symptoms. Splitting doses across the day produces steadier effects.

Be patient. Cardiovascular effects emerge over 8–12 weeks. Acute use does not meaningfully change blood pressure or lipids.

Common misconceptions

Cooked garlic is just as good. It is not for medicinal purposes. Heat destroys the alliinase enzyme needed to produce allicin. Crushing garlic and letting it stand for 10 minutes before cooking preserves more of the activity.

Garlic supplements replace statins. They do not. Garlic produces roughly a 5–10% reduction in LDL cholesterol; statins typically produce 30–50% reductions. Garlic is a useful adjunct, not a substitute for clinically indicated medication.

Odourless garlic supplements don't work. Aged garlic extract has minimal odour and is the most studied form. Odourlessness is not necessarily a sign of inactivity.

More is always better. Above 2,000 mg/day, side effects (heartburn, body odour, bleeding risk) increase without further benefit.

Garlic prevents all infections. It modestly reduces upper respiratory infection frequency in winter. It does not reliably prevent or treat established bacterial infections requiring antibiotics.

FAQ

How long until I notice effects? For blood pressure or cholesterol, 8–12 weeks of consistent use. For cold prevention, benefit shows up across a winter season rather than acutely.

Can I just eat garlic in food? Yes — 1–2 cloves daily provides a meaningful dose, particularly if crushed and left to stand before cooking. Most research uses concentrated supplements, but dietary garlic remains biologically active.

Does it interact with medications? With anticoagulants, antiplatelet drugs, NSAIDs, and HIV protease inhibitors. Mention regular garlic supplements to your prescriber, particularly before surgery.

Does it cause body odour? At higher doses, yes — both breath and skin. Aged garlic extract reduces this substantially compared with fresh garlic or standard powder.

Is it safe in pregnancy? Culinary amounts are fine. High-dose supplements are not well-studied in pregnancy and are generally not recommended.

Evidence grades and benefit rankings on this page are sourced from Examine.com, an independent research database with no industry funding.